Search results for “Fibroblast growth factor receptor” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 1,710 patents, we discovered top 258 key players by total patent application. Janssen Pharmaceutica NV, Five Prime Therapeutics, Inc., Novartis AG are dominant in this area. They take 15.85% of the total patent filing.
Antwerpen, Belgium
Patent: 115
California, United States
Patent: 82
Basel-Stadt, Switzerland
Patent: 74
Indiana, United States
Patent: 74
Delaware, United States
Patent: 72
France
Patent: 65
Massachusetts, United States
Patent: 56
California, United States
Patent: 55
New York, United States
Patent: 41
New York, United States
Patent: 39
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 83 patents, we discovered top 10 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, TransThera Sciences (Nanjing), Inc., Trefoil Therapeutics, Inc. are active in this area.
STARTUP
France
Patent: 62
STARTUP
Jiangsu Sheng, China
Patent: 5
STARTUP
California, United States
Patent: 4
STARTUP
California, United States
Patent: 3
STARTUP
Niedersachsen, Germany
Patent: 2
STARTUP
Texas, United States
Patent: 2
STARTUP
Chiba-ken, Japan
Patent: 2
STARTUP
California, United States
Patent: 2
STARTUP
France
Patent: 2
STARTUP
Saitama-ken, Japan
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 448 patents applied in the last 5 years. We discover 105 most active companies in this area. The fast-growing Janssen Pharmaceutica NV, Incyte Corp., Five Prime Therapeutics, Inc. take 36.38% of patent filing during this period.
Antwerpen, Belgium
Patent: 83
Delaware, United States
Patent: 50
California, United States
Patent: 30
Zhejiang Sheng, China
Patent: 26
STARTUP
France
Patent: 23
California, United States
Patent: 21
Osaka-fu, Japan
Patent: 16
New York, United States
Patent: 15
France
Patent: 14
Centre National De La Recherche Scientif
France
Patent: 11
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 448 patents in last 5 years, we discover 69 new entrants. Betta Pharmaceuticals Co., Ltd., Kinnate Biopharma, Inc., Mitsubishi Tanabe Pharma Corp. are the most active new entrants in this area.
Zhejiang Sheng, China
Patent: 26
California, United States
Patent: 21
Osaka-fu, Japan
Patent: 16
North Carolina, United States
Patent: 10
Tokyo-to, Japan
Patent: 8
Zug, Switzerland
Patent: 6
Guangdong Sheng, China
Patent: 6
Australia
Patent: 6
Jiangsu Sheng, China
Patent: 5
Michigan, United States
Patent: 4
Research Institutions
Order by:
Innovation Intensity
With the analysis among 467 patents, we discovered top 65 universities and scientific research institutions by total patent application. The Salk Institute for Biological Studies, Université Côte dAzur, Université Toulouse III - Paul Sabatier are dominant in this area. They take 29.98% of the total patent filing.
California, United States
Patent: 46
France
Patent: 23
France
Patent: 21
New York, United States
Patent: 15
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 13
Kyoto-fu, Japan
Patent: 12
Zhejiang Sheng, China
Patent: 12
Belgium
Patent: 12
Hovedstaden, Denmark
Patent: 10
Queensland, Australia
Patent: 8
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: